title: Verapamil in the prophylaxis of episodic cluster headache: a double-blind study versus placebo.
abstract: The authors performed a double-blind, double-dummy study to compare the efficacy of verapamil with placebo in the prophylaxis of episodic cluster headache. After 5 days' run-in, 15 patients received verapamil (120 mg tid) and 15 received placebo (tid) for 14 days. The authors found a significant reduction in attack frequency and abortive agents consumption in the verapamil group. Side effects were mild. These findings provide objective evidence for the effectiveness of verapamil in episodic cluster headache prophylaxis.
authors.affiliation: Istituto Nazionale Neurologico Carlo Besta, Milan, Italy.
authors.forename: M
authors.initials: M
authors.lastname: Leone
authors.forename: D
authors.initials: D
authors.lastname: D'Amico
authors.forename: F
authors.initials: F
authors.lastname: Frediani
authors.forename: F
authors.initials: F
authors.lastname: Moschiano
authors.forename: L
authors.initials: L
authors.lastname: Grazzi
authors.forename: A
authors.initials: A
authors.lastname: Attanasio
authors.forename: G
authors.initials: G
authors.lastname: Bussone
mesh_terms: D000328:Adult; D003027:Cluster Headache / Q000188:drug therapy*; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D014700:Verapamil / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D014700:Verapamil